EP0763123A4 - Safe retroviral vectors, their production and use - Google Patents

Safe retroviral vectors, their production and use

Info

Publication number
EP0763123A4
EP0763123A4 EP95921391A EP95921391A EP0763123A4 EP 0763123 A4 EP0763123 A4 EP 0763123A4 EP 95921391 A EP95921391 A EP 95921391A EP 95921391 A EP95921391 A EP 95921391A EP 0763123 A4 EP0763123 A4 EP 0763123A4
Authority
EP
European Patent Office
Prior art keywords
production
retroviral vectors
safe
safe retroviral
vectors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95921391A
Other languages
German (de)
French (fr)
Other versions
EP0763123A1 (en
Inventor
Shui-On Leung
Chien-Hsing Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunomedics Inc
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of EP0763123A1 publication Critical patent/EP0763123A1/en
Publication of EP0763123A4 publication Critical patent/EP0763123A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45Transferases (2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16041Use of virus, viral particle or viral elements as a vector
    • C12N2740/16043Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP95921391A 1994-06-07 1995-06-07 Safe retroviral vectors, their production and use Withdrawn EP0763123A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25577194A 1994-06-07 1994-06-07
US255771 1994-06-07
PCT/US1995/006594 WO1995033842A1 (en) 1994-06-07 1995-06-07 Safe retroviral vectors, their production and use

Publications (2)

Publication Number Publication Date
EP0763123A1 EP0763123A1 (en) 1997-03-19
EP0763123A4 true EP0763123A4 (en) 1998-08-12

Family

ID=22969789

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95921391A Withdrawn EP0763123A4 (en) 1994-06-07 1995-06-07 Safe retroviral vectors, their production and use

Country Status (3)

Country Link
EP (1) EP0763123A4 (en)
AU (1) AU2648295A (en)
WO (1) WO1995033842A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200811B1 (en) * 1996-04-02 2001-03-13 The Regents Of The University Of California Cell transformation vector comprising an HIV-2 packaging site nucleic acid and an HIV-1 GAG protein
US6027721A (en) * 1996-05-20 2000-02-22 Cytotherapeutics, Inc. Device and method for encapsulated gene therapy

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002805A2 (en) * 1989-08-18 1991-03-07 Viagene, Inc. Recombinant retroviruses delivering vector constructs to target cells
WO1992005266A2 (en) * 1990-09-21 1992-04-02 Viagene, Inc. Packaging cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1038306A (en) * 1988-03-21 1989-12-27 维吉恩公司 Recombinant retroviruses
EP0454781B1 (en) * 1989-01-23 1998-12-16 Chiron Corporation Recombinant cells for therapies of infection and hyperproliferative disorders and preparation thereof
WO1990012087A1 (en) * 1989-04-05 1990-10-18 Novacell Corporation Infectious targetted replication-defective virion
GB9104165D0 (en) * 1991-02-27 1991-04-17 Wellcome Found Novel entities for hiv therapy

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991002805A2 (en) * 1989-08-18 1991-03-07 Viagene, Inc. Recombinant retroviruses delivering vector constructs to target cells
WO1992005266A2 (en) * 1990-09-21 1992-04-02 Viagene, Inc. Packaging cells

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9533842A1 *

Also Published As

Publication number Publication date
WO1995033842A1 (en) 1995-12-14
AU2648295A (en) 1996-01-04
EP0763123A1 (en) 1997-03-19

Similar Documents

Publication Publication Date Title
ZA919797B (en) Bicyclo-5,6-dihydro-7h-pyrrolo-1,20-imidazol-7-ols and 7-ones
EP0458333A3 (en) Polyisocyanato-isocyanurate, and preparation process and use of the same
EP0421210A3 (en) Triazole compounds, their production and use
IL95775A0 (en) Oxazole-and thiazole-carboxamides,their manufacture and their use as herbicides
HUT74310A (en) Flame-resistant polycarbamide foam, production process and use thereof
EP0492248A3 (en) Intumescent sheet, its manufacture and use
HUP0001603A3 (en) Cycloalkylalkanecarboxamides and the production and use thereof
GB2246139B (en) Polytheresters,their production and use
EP0738144A4 (en) Phenylmethyl hexanamides, and the use thereof
GB2294941B (en) Dyestuff mixtures, their production and use
HK1025782A1 (en) 1:2chromium complex dyes, the production and use thereof
GB2276546B (en) Improved iodophors,production and use thereof
EP0446877A3 (en) Triazoles, their production and use
AU122739S (en) Dry shaver
HUP0000498A3 (en) Novel calpaines, production and use thereof
PL319406A1 (en) Novel heterocyclically substituted imidazoqunoxalinones, their production and application
EP0763123A4 (en) Safe retroviral vectors, their production and use
EP0442086A3 (en) Graftcopolymers, their preparation and their use
HUP0004027A2 (en) New tissue-specific calpaines, their production and their use
ZA955128B (en) Novel amido-quinoxalinediones the preparation and use thereof
GB9400302D0 (en) Flocculation-stable pigments, processes for their preparation and their use
EP0274066A3 (en) Benzothiazolones, and their production and use
EP0699719A3 (en) Azodyes, process for their preparation and the use thereof
HU9600660D0 (en) Butenol-triazolyl derivatives, their manufacture and use as microbicides
EP0258773A3 (en) Benzothiazolones, and their production and use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970103

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE FR GB IT LI NL

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): CH DE FR GB IT LI NL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19980814